dilluns, 23 de març del 2015

BioTelemetry pays $6m to settle CardioNet fraud charges




BioTelemetry agrees to pay more than $6 million to settle federal charges that its CardioNet subsidiary overbilled Medicare for its remote cardiac monitoring services.






BioTelemetry Inc. agreed to fork over $6.4 million to settle federal charges that its CardioNet subsidiary overbilled Medicare for unnecessary outpatient services.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1N5R5mq

Cap comentari:

Publica un comentari a l'entrada